TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review

Muller Marie; DAmico Ferdinando; Bonovas Stefanos; Danese Silvio; Peyrin-Biroulet Laurent

首页> 外文期刊>Journal of Crohn’s & colitis >TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review

【24h】

TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review

机译：炎症性肠病患者的TNF抑制剂和恶性肿瘤风险：系统审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and Aims: The association between tumour necrosis factor inhibitors [TNFi] and malignancy in patients with inflammatory bowel disease [IBD] is not well understood. Our aim was to systematically evaluate the impact of TNFi use on risk of malignancy in IBD patients in daily clinical practice.

机译：背景和目的：肿瘤坏死因子抑制剂[TNFi]与炎症性肠病[IBD]患者恶性肿瘤之间的关系尚不清楚。我们的目的是在日常临床实践中系统评估TNFi的使用对IBD患者恶性肿瘤风险的影响。

著录项

来源
《Journal of Crohn’s & colitis》 |2021年第5期|共20页
作者
Muller Marie; DAmico Ferdinando; Bonovas Stefanos; Danese Silvio; Peyrin-Biroulet Laurent;
展开▼
作者单位

Univ Lorraine Nancy Univ Hosp Dept Gastroenterol Nancy France;

Univ Lorraine Nancy Univ Hosp Dept Gastroenterol Nancy France;

Humanitas Univ Dept Biomed Sci Milan Italy;

Humanitas Univ Dept Biomed Sci Milan Italy;

Univ Lorraine Nancy Univ Hosp Dept Gastroenterol Nancy France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类杆菌传染病;
关键词
Malignancy; cancer; TNF inhibitors; inflammatory bowel disease;

机译：恶性肿瘤;癌症;TNF抑制剂;炎症性肠病;
入库时间 2022-08-20 19:50:33

相似文献

外文文献
中文文献
专利

1. Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis [J] . Bonovas Stefanos, Fiorino Gionata, Allocca Mariangela, Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第10期

机译：生物疗法和炎性肠病患者感染和恶性肿瘤的风险：系统评价和网络Meta分析
2. Does Inflammatory Bowel Disease Increase the Risk of Malignancies in Patients with Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis [J] . Hamdeh Shadi, Ahmad Dina, Mouchli Mohamad, The American Journal of Gastroenterology . 2016,第Suppla1期

机译：炎症性肠病是否会增加原发性硬化性胆管炎患者发生恶性肿瘤的风险：系统评价和荟萃分析
3. Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis [J] . Bonovas Stefanos, Fiorino Gionata, Allocca Mariangela, Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第10期

机译：炎症性肠病患者的生物疗法和感染和恶性肿瘤风险：系统审查和网络元分析
4. Patients at risk for colorectal cancer in inflammatory bowel disease [C] . C. N. BERNSTEIN Falk Workshop . 2009

机译：炎症性肠疾病中结直肠癌风险的患者
5. Antipsychotic Compounds Inhibit Inflammatory Stimulation of TNFα from Microglia: Relevance to Hemorrhagic Stroke, Alzheimer’s Disease and Other Inflammatory Diseases [D] . Vicari, James Michael 2019

机译：抗精神病化合物抑制小胶质细胞的TNFα的炎症刺激：与出血性中风，阿尔茨海默氏病和其他炎症性疾病的相关性
6. Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocol [O] . Amy Johnston, Sabrina Natarajan, Meghan Hayes, 2018

机译：炎症性肠病患者TNF-α抑制剂的加速诱导方案：范围审查协议
7. Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis [O] . Stefanos Bonovas, Gionata Fiorino, Mariangela Allocca, 2016

机译：炎症性肠病患者的生物疗法和感染和恶性肿瘤风险：系统审查和网络元分析
8. Progression of Inflammatory Bowel Disease to Cancer: Is the Patient Better Off without Lymphatic Vessels or Nodes (or Angiopoietin 2) [R] . Witte, M H 2013

机译：炎症性肠病进展为癌症：如果没有淋巴管或淋巴结（或促血管生成素2），患者会更好吗？

TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review

摘要

著录项

相似文献

相关主题

期刊订阅